Literature DB >> 19755184

Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

E Sally Ward1, Raimund J Ober.   

Abstract

The MHC Class I-related receptor, FcRn, transports antibodies of the immunoglobulin G (IgG) class within and across a diverse array of different cell types. Through this transport, FcRn serves multiple roles throughout adult life that extend well beyond its earlier defined function of transcytosing IgGs from mother to offspring. These roles include the maintenance of IgG levels and the delivery of antigen in the form of immune complexes to degradative compartments within cells. Recent studies have led to significant advances in knowledge of the intracellular trafficking of FcRn and (engineered) IgGs at both the molecular and cellular levels. The engineering of FcRn-IgG (or Fc) interactions to generate antibodies of increased longevity represents an area of active interest, particularly in the light of the expanding use of antibodies in therapy. The strict pH dependence of FcRn-IgG interactions, with binding at pH 6 that becomes essentially undetectable as near neutral pH is approached, is essential for efficient transport. The requirement for retention of low affinity at near neutral pH increases the complexity of engineering antibodies for increased half-life. Conversely, engineered IgGs that have gained significant binding for FcRn at this pH can be potent inhibitors of FcRn that lower endogenous IgG levels and have multiple potential uses as therapeutics. In addition, molecular studies of FcRn-IgG interactions indicate that mice have limitations as preclinical models for FcRn function, primarily due to cross-species differences in FcRn-binding specificity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755184      PMCID: PMC4485553          DOI: 10.1016/S0065-2776(09)03004-1

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  190 in total

1.  Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding.

Authors:  W L Martin; A P West; L Gan; P J Bjorkman
Journal:  Mol Cell       Date:  2001-04       Impact factor: 17.970

2.  Sar1p N-terminal helix initiates membrane curvature and completes the fission of a COPII vesicle.

Authors:  Marcus C S Lee; Lelio Orci; Susan Hamamoto; Eugene Futai; Mariella Ravazzola; Randy Schekman
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

3.  The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans.

Authors:  M Firan; R Bawdon; C Radu; R J Ober; D Eaken; F Antohe; V Ghetie; E S Ward
Journal:  Int Immunol       Date:  2001-08       Impact factor: 4.823

4.  An Fc receptor structurally related to MHC class I antigens.

Authors:  N E Simister; K E Mostov
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

5.  Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface.

Authors:  P Isomäki; M Panesar; A Annenkov; J M Clark; B M Foxwell; Y Chernajovsky; A P Cope
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

6.  Redistribution of the sheep neonatal Fc receptor in the mammary gland around the time of parturition in ewes and its localization in the small intestine of neonatal lambs.

Authors:  Balázs Mayer; Anna Zolnai; László V Frenyó; Veronika Jancsik; Zoltán Szentirmay; Lennart Hammarström; Imre Kacskovics
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

7.  The effects of corticosterone and cortisone on the uptake of polyvinyl pyrrolidone and the transmission of immunoglobulin G by the small intestine in young rats.

Authors:  B Morris; R Morris
Journal:  J Physiol       Date:  1976-01       Impact factor: 5.182

8.  Rab11 regulates recycling through the pericentriolar recycling endosome.

Authors:  O Ullrich; S Reinsch; S Urbé; M Zerial; R G Parton
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

9.  Mouse MHC class I-like Fc receptor encoded outside the MHC.

Authors:  J J Ahouse; C L Hagerman; P Mittal; D J Gilbert; N G Copeland; N A Jenkins; N E Simister
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

10.  Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedules.

Authors:  J E Frödin; A K Lefvert; H Mellstedt
Journal:  Cancer Res       Date:  1990-08-15       Impact factor: 12.701

View more
  71 in total

1.  Human Immunoglobulin Heavy Gamma Chain Polymorphisms: Molecular Confirmation Of Proteomic Assessment.

Authors:  Magalie Dambrun; Célia Dechavanne; Alexandra Emmanuel; Florentin Aussenac; Marjorie Leduc; Chiara Giangrande; Joëlle Vinh; Jean-Michel Dugoujon; Marie-Paule Lefranc; François Guillonneau; Florence Migot-Nabias
Journal:  Mol Cell Proteomics       Date:  2017-03-06       Impact factor: 5.911

Review 2.  Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.

Authors:  Imre Kacskovics; Judit Cervenak; Anna Erdei; Richard A Goldsby; John E Butler
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

3.  Monoclonal antibodies directed against human FcRn and their applications.

Authors:  Gregory J Christianson; Victor Z Sun; Shreeram Akilesh; Emanuele Pesavento; Gabriele Proetzel; Derry C Roopenian
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

4.  Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.

Authors:  Algirdas Grevys; Malin Bern; Stian Foss; Diane Bryant Bratlie; Anders Moen; Kristin Støen Gunnarsen; Audun Aase; Terje Einar Michaelsen; Inger Sandlie; Jan Terje Andersen
Journal:  J Immunol       Date:  2015-04-22       Impact factor: 5.422

Review 5.  FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.

Authors:  Michal Pyzik; Timo Rath; Wayne I Lencer; Kristi Baker; Richard S Blumberg
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

Review 6.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

7.  Using multifocal plane microscopy to reveal novel trafficking processes in the recycling pathway.

Authors:  Zhuo Gan; Sripad Ram; Raimund J Ober; E Sally Ward
Journal:  J Cell Sci       Date:  2013-01-23       Impact factor: 5.285

8.  Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.

Authors:  Sung-Youl Ko; Amarendra Pegu; Rebecca S Rudicell; Zhi-yong Yang; M Gordon Joyce; Xuejun Chen; Keyun Wang; Saran Bao; Thomas D Kraemer; Timo Rath; Ming Zeng; Stephen D Schmidt; John-Paul Todd; Scott R Penzak; Kevin O Saunders; Martha C Nason; Ashley T Haase; Srinivas S Rao; Richard S Blumberg; John R Mascola; Gary J Nabel
Journal:  Nature       Date:  2014-08-13       Impact factor: 49.962

Review 9.  Targeting FcRn for the modulation of antibody dynamics.

Authors:  E Sally Ward; Siva Charan Devanaboyina; Raimund J Ober
Journal:  Mol Immunol       Date:  2015-03-09       Impact factor: 4.407

Review 10.  Targeting FcRn for therapy: from live cell imaging to in vivo studies in mice.

Authors:  E Sally Ward; Ramraj Velmurugan; Raimund J Ober
Journal:  Immunol Lett       Date:  2014-02-23       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.